1. Home
  2. AQST vs CVEO Comparison

AQST vs CVEO Comparison

Compare AQST & CVEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • CVEO
  • Stock Information
  • Founded
  • AQST 2004
  • CVEO 1977
  • Country
  • AQST United States
  • CVEO United States
  • Employees
  • AQST N/A
  • CVEO N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • CVEO Hotels/Resorts
  • Sector
  • AQST Health Care
  • CVEO Consumer Discretionary
  • Exchange
  • AQST Nasdaq
  • CVEO Nasdaq
  • Market Cap
  • AQST 272.9M
  • CVEO 281.2M
  • IPO Year
  • AQST 2018
  • CVEO N/A
  • Fundamental
  • Price
  • AQST $3.25
  • CVEO $22.57
  • Analyst Decision
  • AQST Strong Buy
  • CVEO Strong Buy
  • Analyst Count
  • AQST 6
  • CVEO 1
  • Target Price
  • AQST $10.67
  • CVEO $27.00
  • AVG Volume (30 Days)
  • AQST 1.6M
  • CVEO 90.4K
  • Earning Date
  • AQST 08-05-2025
  • CVEO 07-29-2025
  • Dividend Yield
  • AQST N/A
  • CVEO 4.41%
  • EPS Growth
  • AQST N/A
  • CVEO N/A
  • EPS
  • AQST N/A
  • CVEO N/A
  • Revenue
  • AQST $54,228,000.00
  • CVEO $660,046,000.00
  • Revenue This Year
  • AQST N/A
  • CVEO N/A
  • Revenue Next Year
  • AQST $45.71
  • CVEO $4.45
  • P/E Ratio
  • AQST N/A
  • CVEO N/A
  • Revenue Growth
  • AQST 5.29
  • CVEO N/A
  • 52 Week Low
  • AQST $2.12
  • CVEO $18.01
  • 52 Week High
  • AQST $5.80
  • CVEO $28.92
  • Technical
  • Relative Strength Index (RSI)
  • AQST 54.57
  • CVEO 59.44
  • Support Level
  • AQST $3.20
  • CVEO $22.12
  • Resistance Level
  • AQST $3.61
  • CVEO $22.74
  • Average True Range (ATR)
  • AQST 0.28
  • CVEO 0.57
  • MACD
  • AQST -0.00
  • CVEO -0.03
  • Stochastic Oscillator
  • AQST 50.44
  • CVEO 50.22

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About CVEO Civeo Corporation (Canada)

Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia and the United States. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, Australia and the United States.

Share on Social Networks: